Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Total Liabilities (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Total Liabilities for 11 consecutive years, with $112.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 16.73% year-over-year to $112.3 million, compared with a TTM value of $112.3 million through Dec 2025, down 16.73%, and an annual FY2025 reading of $112.3 million, down 16.73% over the prior year.
  • Total Liabilities was $112.3 million for Q4 2025 at Wave Life Sciences, up from $109.0 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $294.1 million in Q1 2023 and bottomed at $105.2 million in Q2 2025.
  • Average Total Liabilities over 5 years is $179.9 million, with a median of $177.4 million recorded in 2021.
  • The sharpest move saw Total Liabilities surged 84.35% in 2023, then plummeted 48.53% in 2025.
  • Year by year, Total Liabilities stood at $166.6 million in 2021, then rose by 10.18% to $183.6 million in 2022, then grew by 23.88% to $227.4 million in 2023, then plummeted by 40.73% to $134.8 million in 2024, then fell by 16.73% to $112.3 million in 2025.
  • Business Quant data shows Total Liabilities for WVE at $112.3 million in Q4 2025, $109.0 million in Q3 2025, and $105.2 million in Q2 2025.